MSCM
SAGE

McElhenny Sheffield Capital Management’s Sage Therapeutics SAGE Stock Holding History

McElhenny Sheffield Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8
Closed -$305 – 510
2022
Q4 		$305 Buy
+8
New +$305 ﹤0.01% 651